Related Experiment Video
Updated: Jul 31, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
Published on: April 4, 2011
Localization of a new neutralizing epitope on the mumps virus hemagglutinin-neuraminidase protein
M G Cusi1, S Fischer, R Sedlmeier
1Department of Molecular Biology, Section of Microbiology, University of Siena, Via Laterina, 8-53100, Siena, Italy. cusi@unisi.it
Abstract:
Four protein fragments which span the entire hemagglutinin-neuraminidase protein (HN) of mumps virus were expressed in HeLa cells and cell extracts were tested for their capability to induce neutralizing antibodies in mice. Fragment HN3 (aa 213-372) was able to induce the production of hemagglutination-inhibiting and neutralizing antibodies. When a subfragment of HN3, the synthetic peptide NSTLGVKSAREF (aa 329-340 of HN) was used for immunization, hemagglutination-inhibiting and neutralizing antibodies against mumps wild type virus but not against the Urabe Am9 vaccine virus were raised. The peptide could, therefore, contain a new epitope, which may be critical for protective host humoral immune response.
Insights
Researchers identified a specific mumps virus protein fragment (HN3) that elicits neutralizing antibodies. A smaller peptide from this fragment induced antibodies against wild-type mumps but not the Urabe Am9 vaccine, suggesting a critical new epitope for immune response.
Area of Science:
- Virology and Immunology
- Molecular Biology
Background:
- The hemagglutinin-neuraminidase (HN) protein of mumps virus is crucial for viral infectivity and is a target for immune responses.
- Understanding specific epitopes on the HN protein is essential for developing effective vaccines and antiviral therapies against mumps virus.
Purpose of the Study:
- To identify immunogenic fragments of the mumps virus hemagglutinin-neuraminidase (HN) protein capable of inducing neutralizing antibodies.
- To investigate a specific peptide epitope within the HN protein for its potential role in eliciting protective humoral immunity against mumps virus.
Main Methods:
- Expression of four full-length hemagglutinin-neuraminidase (HN) protein fragments in HeLa cells.
- Immunization of mice with cell extracts containing HN fragments and a synthetic peptide derived from HN3.
- Assays to measure hemagglutination-inhibiting and neutralizing antibody production against mumps wild-type and Urabe Am9 vaccine viruses.
Main Results:
- Fragment HN3 (amino acids 213-372) successfully induced hemagglutination-inhibiting and neutralizing antibodies.
- A synthetic peptide (NSTLGVKSAREF, amino acids 329-340) from HN3 elicited antibodies against wild-type mumps virus.
- Antibodies generated by the synthetic peptide did not neutralize the Urabe Am9 vaccine strain of mumps virus.
Conclusions:
- The HN3 fragment contains immunogenic regions capable of stimulating a humoral immune response against mumps virus.
- The synthetic peptide NSTLGVKSAREF may represent a novel epitope critical for protective immunity.
- This epitope's differential reactivity suggests potential for targeted vaccine development or distinguishing between wild-type and vaccine-induced immunity.
Related Concept Videos
Leaky Scanning
Inhibitors Of Virion Release

